Neutralizing anti-IL-23p19 antibody (anti-IL23p19) treatment before the signs of arthritis onset significantly decreased arthritis score and histological severity in CIA mice, but the treatment lost the inhibitory effects when given after the onset of arthritis (26). This evidence concerns the gene IL23A and arthritic joint disease.